Page last updated: 2024-08-21

pyrazines and cudc-907

pyrazines has been researched along with cudc-907 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dzinic, SH; Edwards, H; Ge, Y; Knight, T; Kushner, J; Li, J; Lin, H; Ma, J; Polin, L; Qiao, X; Su, Y; Taub, JW; Wang, G; Wang, J; Wang, L; Wang, Y; White, K	1

Other Studies

1 other study(ies) available for pyrazines and cudc-907

Article	Year
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. Blood cancer journal, 2021, 06-07, Volume: 11, Issue:6 Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, Transgenic; Morpholines; Pyrazines; Pyrimidines; THP-1 Cells; Xenograft Model Antitumor Assays	2021

Article

Year

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML.

Blood cancer journal, 2021, 06-07, Volume: 11, Issue:6

Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, Transgenic; Morpholines; Pyrazines; Pyrimidines; THP-1 Cells; Xenograft Model Antitumor Assays

2021